Michael Elliott FRCP, FFPM is a physician executive with over 30 years’ experience in global biopharma. He was most recently VP Medical Affairs Europe at Gilead Sciences for 13 years, leading a 300-person team and overseeing 13 medicine launches across HIV, hepatology, and oncology. Before Gilead, he spent 15 years in VP roles at GSK in the US, Australia, and Asia Pacific, spanning Clinical Development, Medical Affairs, and commercialisation; in both regional and global roles.

Michael joined Advance AI as Chief Medical Officer in April 2026. He holds an MBA from Melbourne Business School and serves as a board director at Medicines Development for Global Health and as a trustee of the UK charity MyBigCareer.